In these unprecedented times, we are coming together to achieve one shared goal: to beat COVID-19. The decades-long investments we have made in new technology, research and treatments have prepared us to act swiftly:
We are rapidly screening our vast global libraries of medicines to identify potential treatments and have numerous clinical trials underway to test new and existing therapies.
We are dedicating our top scientists and using our investments in new technologies to speed the development of safe and effective vaccines.
We are sharing the learnings from clinical trials in real time with governments and other companies to advance the development of additional therapies.
We are expanding our unique manufacturing
capabilities and sharing available capacity to
ramp up production once a successful medicine
or vaccine is developed.
We are collaborating with government agencies,
hospitals, doctors and others to donate supplies
and medicines to help those affected around
We are working with governments and insurers
to ensure that when new treatments and
vaccines are approved they will be available
and affordable for patients.